Phase 2 study with Baker's Antifol in solid tumors.

Rodriguez, V; Richman, S P; Benjamin, R S; Burgess, M A; Murphy, W K; Valdivieso, M; Banner, R L; Gutterman, J U; Bodey, G P; Freireich, E J

Rodriguez, V; Richman, S P; Benjamin, R S; Burgess, M A; Murphy, W K; Valdivieso, M; Banner, R L; Gutterman, J U; Bodey, G P; Freireich, E J.

Cancer Res ; 37(4): 980-3, 1977 Apr.

Article in En | MEDLINE | ID: mdl-139205

Subject(s)

Folic Acid Antagonists/therapeutic use; Neoplasms/drug therapy; Triazines/therapeutic use; Adenocarcinoma/drug therapy; Adolescent; Adult; Aged; Carcinoma, Squamous Cell/drug therapy; Colonic Neoplasms/drug therapy; Drug Eruptions/etiology; Female; Folic Acid Antagonists/administration & dosage; Folic Acid Antagonists/adverse effects; Head and Neck Neoplasms/drug therapy; Humans; Kidney Neoplasms/drug therapy; Lung Neoplasms/drug therapy; Male; Melanoma/drug therapy; Middle Aged; Rectal Neoplasms/drug therapy; Remission, Spontaneous; Sarcoma/drug therapy; Stomatitis/chemically induced; Triazines/administration & dosage

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Triazines / Folic Acid Antagonists / Neoplasms Type of study: Etiology_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 1977 Type: Article

Search on Google

XML

PubMed Links